earnings
MB
NASDAQ · MBRX
Moleculin Biotech, Inc.
Healthcare · Biotechnology
$7.87
Down-$0.73 (-9.28%)
Updated Nov 17, 2026, 1:20 AM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.01M
- P/E ratio
- -0.18
- Dividend yield
- 0.00%
- 52-week range
- $0.16 – $12.19
- Volume
- 9.9K
- Avg. volume
- 194.99K
Price performance · MBRX
MBRX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
MBRX closed at $7.87 after 20 trading sessions, up 48.49% for the selected period.
- Last close
- $7.87
- Period change
- +48.49%
- Period low
- $5.30
- Period high
- $9.27
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $8.00 | $8.101 | $7.71 | $7.87 | 9.9K |
| Nov 12, 2026 | $8.77 | $8.90 | $7.90 | $8.06 | 42.18K |
| Nov 11, 2026 | $8.08 | $8.40 | $8.00 | $8.10 | 14.14K |
| Nov 10, 2026 | $8.51 | $8.87 | $8.01 | $8.06 | 20.75K |
| Nov 9, 2026 | $8.83 | $8.88 | $8.52 | $8.66 | 17.39K |
| Nov 6, 2026 | $8.88 | $8.94 | $8.53 | $8.70 | 14.28K |
| Nov 5, 2026 | $8.46 | $8.96 | $7.74 | $8.73 | 25.17K |
| Nov 4, 2026 | $8.13 | $8.6508 | $8.13 | $8.46 | 13.78K |
| Nov 3, 2026 | $8.27 | $8.4199 | $8.27 | $8.30 | 12.49K |
| Nov 2, 2026 | $7.96 | $8.50 | $7.65 | $8.32 | 12.96K |
| Oct 30, 2026 | $8.80 | $9.00 | $7.90 | $7.90 | 31.72K |
| Oct 29, 2026 | $8.70 | $8.84 | $8.079 | $8.72 | 33.99K |
| Oct 28, 2026 | $9.41 | $10.24 | $8.10 | $8.745 | 101.86K |
| Oct 27, 2026 | $7.18 | $9.7194 | $7.17 | $9.265 | 188.86K |
| Oct 26, 2026 | $6.59 | $7.25 | $6.50 | $7.085 | 25.46K |
| Oct 23, 2026 | $6.05 | $6.59 | $5.6483 | $6.50 | 27.67K |
| Oct 22, 2026 | $6.13 | $6.1638 | $5.46 | $5.89 | 59.13K |
| Oct 21, 2026 | $6.00 | $6.58 | $6.00 | $6.31 | 42K |
| Oct 20, 2026 | $5.74 | $6.4025 | $5.24 | $6.19 | 131.77K |
| Oct 19, 2026 | $5.60 | $5.60 | $4.42 | $5.30 | 53.31K |
Latest MBRX news
The latest Smart Investors Daily articles mentioning MBRX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

